These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1581717)

  • 1. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.
    Hawkins MM; Wilson LM; Stovall MA; Marsden HB; Potok MH; Kingston JE; Chessells JM
    BMJ; 1992 Apr; 304(6832):951-8. PubMed ID: 1581717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
    Sandoval C; Pui CH; Bowman LC; Heaton D; Hurwitz CA; Raimondi SC; Behm FG; Head DR
    J Clin Oncol; 1993 Jun; 11(6):1039-45. PubMed ID: 8388919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
    Le Deley MC; Leblanc T; Shamsaldin A; Raquin MA; Lacour B; Sommelet D; Chompret A; Cayuela JM; Bayle C; Bernheim A; de Vathaire F; Vassal G; Hill C;
    J Clin Oncol; 2003 Mar; 21(6):1074-81. PubMed ID: 12637473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.
    Hawkins MM; Wilson LM; Burton HS; Potok MH; Winter DL; Marsden HB; Stovall MA
    J Natl Cancer Inst; 1996 Mar; 88(5):270-8. PubMed ID: 8614005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood.
    Haddy N; Le Deley MC; Samand A; Diallo I; Guérin S; Guibout C; Oberlin O; Hawkins M; Zucker JM; de Vathaire F
    Eur J Cancer; 2006 Nov; 42(16):2757-64. PubMed ID: 16965909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
    BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy.
    Allodji RS; Schwartz B; Veres C; Haddy N; Rubino C; Le Deley MC; Labbé M; Diop F; Jackson A; Dayet F; Benabdennebi A; Llanas D; Vu Bezin J; Chavaudra J; Lefkopoulos D; Deutsch E; Oberlin O; de Vathaire F; Diallo I
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):658-67. PubMed ID: 26461008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
    Smith MA; Rubinstein L; Ungerleider RS
    Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
    van Leeuwen FE; Chorus AM; van den Belt-Dusebout AW; Hagenbeek A; Noyon R; van Kerkhoff EH; Pinedo HM; Somers R
    J Clin Oncol; 1994 May; 12(5):1063-73. PubMed ID: 8164031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
    Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
    J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
    Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
    N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
    Smith MA; Rubinstein L; Cazenave L; Ungerleider RS; Maurer HM; Heyn R; Khan FM; Gehan E
    J Natl Cancer Inst; 1993 Apr; 85(7):554-8. PubMed ID: 8455202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies.
    Little MP; Wakeford R; Borrego D; French B; Zablotska LB; Adams MJ; Allodji R; de Vathaire F; Lee C; Brenner AV; Miller JS; Campbell D; Pearce MS; Doody MM; Holmberg E; Lundell M; Sadetzki S; Linet MS; Berrington de González A
    Lancet Haematol; 2018 Aug; 5(8):e346-e358. PubMed ID: 30026010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias.
    Ellis M; Ravid M; Lishner M
    Leuk Lymphoma; 1993 Sep; 11(1-2):9-13. PubMed ID: 8220158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of leukaemia and non-Hodgkin's lymphoma among children aged 0-4 years living in west Berkshire and north Hampshire health districts.
    Roman E; Watson A; Beral V; Buckle S; Bull D; Baker K; Ryder H; Barton C
    BMJ; 1993 Mar; 306(6878):615-21. PubMed ID: 8461811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimising the long-term adverse effects of childhood leukaemia therapy.
    Langebrake C; Reinhardt D; Ritter J
    Drug Saf; 2002; 25(15):1057-77. PubMed ID: 12452732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.
    Smith MA; Rubinstein L; Anderson JR; Arthur D; Catalano PJ; Freidlin B; Heyn R; Khayat A; Krailo M; Land VJ; Miser J; Shuster J; Vena D
    J Clin Oncol; 1999 Feb; 17(2):569-77. PubMed ID: 10080601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria.
    Gardner MJ; Snee MP; Hall AJ; Powell CA; Downes S; Terrell JD
    BMJ; 1990 Feb; 300(6722):423-9. PubMed ID: 2107892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-associated leukemia following testicular cancer.
    Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
    J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.